Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a randomized, double-blind, placebo-controlled, cross-over phase II prevention trial (crossover assigment) evaluating Lacticaseibacillus rhamnosus GG (LGG) or placebo in patients with metastatic colorectal cancer on 1st Line CAPOX treatment
Effect on the treatment-related grade 2 to 4 diarrhea, numbers of bowel movements per day
No published results were found as of February 2026
…